Literature DB >> 25110459

Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.

Michael J Mitchell1, Michael R King1.   

Abstract

Cancer metastasis, the process of cancer cell migration from a primary to distal location, typically leads to a poor patient prognosis. Hematogenous metastasis is initiated by intravasation of circulating tumor cells (CTCs) into the bloodstream, which are then believed to adhere to the luminal surface of the endothelium and extravasate into distal locations. Apoptotic agents such as tumor necrosis factor (TNF) apoptosis-inducing ligand (TRAIL), whether in soluble ligand form or expressed on the surface of natural killer (NK) cells, have shown promise in treating CTCs to reduce the probability of metastasis. The role of hemodynamic shear forces in altering the cancer cell response to receptor-mediated apoptosis has not been previously investigated. Here, we report that human colon cancer COLO 205 and prostate cancer PC-3 cells exposed to a uniform fluid shear stress in a cone-and-plate viscometer become sensitized to TRAIL-induced apoptosis. Shear-induced sensitization directly correlated with the application of fluid shear stress, and TRAIL-induced apoptosis increased in a fluid shear stress force- and time-dependent manner. In contrast, TRAIL-induced necrosis was not affected by the application fluid shear stress. Interestingly, fluid shear stress did not sensitize cancer cells to apoptosis when treated with doxorubicin, which also induces apoptosis in cancer cells. Caspase inhibition experiments revealed that shear stress-induced sensitization to TRAIL occurs via caspase-dependent apoptosis. These results suggest that physiological fluid shear force can modulate receptor-mediated apoptosis of cancer cells in the presence of apoptotic agents.

Entities:  

Keywords:  TRAIL; cancer; caspase; death receptors; mechanotransduction; shear stress

Year:  2013        PMID: 25110459      PMCID: PMC4124740          DOI: 10.1088/1367-2630/15/1/015008

Source DB:  PubMed          Journal:  New J Phys        ISSN: 1367-2630            Impact factor:   3.729


  51 in total

1.  ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and TRAIL-induced apoptosis.

Authors:  Venturina Stagni; Michele Mingardi; Simonetta Santini; Danilo Giaccari; Daniela Barilà
Journal:  Carcinogenesis       Date:  2010-09-27       Impact factor: 4.944

2.  Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.

Authors:  Holly K Koblish; Shuyuan Zhao; Carol F Franks; Robert R Donatelli; Rose M Tominovich; Louis V LaFrance; Kristi A Leonard; Joan M Gushue; Daniel J Parks; Raul R Calvo; Karen L Milkiewicz; Juan José Marugán; Pierre Raboisson; Maxwell D Cummings; Bruce L Grasberger; Dana L Johnson; Tianbao Lu; Christopher J Molloy; Anna C Maroney
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

Review 3.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 4.  Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity.

Authors:  Melody A Swartz; Amanda W Lund
Journal:  Nat Rev Cancer       Date:  2012-02-24       Impact factor: 60.716

5.  TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.

Authors:  Olivier Meurette; Amélie Rebillard; Laurence Huc; Gwenaëlle Le Moigne; Delphine Merino; Olivier Micheau; Dominique Lagadic-Gossmann; Marie-Thérèse Dimanche-Boitrel
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 6.  The physics of cancer: the role of physical interactions and mechanical forces in metastasis.

Authors:  Denis Wirtz; Konstantinos Konstantopoulos; Peter C Searson
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

7.  WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

Authors:  Sireesha V Garimella; Andrea Rocca; Stanley Lipkowitz
Journal:  Mol Cancer Res       Date:  2011-11-23       Impact factor: 5.852

8.  5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.

Authors:  S Fulda; K-M Debatin
Journal:  Oncogene       Date:  2006-04-10       Impact factor: 9.867

9.  Shear-induced resistance to neutrophil activation via the formyl peptide receptor.

Authors:  Michael J Mitchell; Michael R King
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Authors:  M J Smyth; E Cretney; K Takeda; R H Wiltrout; L M Sedger; N Kayagaki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  63 in total

Review 1.  Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?

Authors:  Ana Sofia Azevedo; Gautier Follain; Shankar Patthabhiraman; Sébastien Harlepp; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2015-08-27       Impact factor: 3.405

2.  Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade.

Authors:  Hongchi Yu; Yang Shen; Jingsi Jin; Yingying Zhang; Tang Feng; Xiaoheng Liu
Journal:  Cell Adh Migr       Date:  2017-06-22       Impact factor: 3.405

3.  Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  Biomaterials       Date:  2015-04-17       Impact factor: 12.479

4.  Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform.

Authors:  Priya Gopinathan; Lien-Yu Hung; Chih-Hung Wang; Nai-Jung Chiang; Yu-Chun Wang; Yan-Shen Shan; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2017-07-05       Impact factor: 2.800

Review 5.  Leukocytes as carriers for targeted cancer drug delivery.

Authors:  Michael J Mitchell; Michael R King
Journal:  Expert Opin Drug Deliv       Date:  2014-10-01       Impact factor: 6.648

6.  Hemodynamic shear stress induces protective autophagy in HeLa cells through lipid raft-mediated mechanotransduction.

Authors:  Joyjyoti Das; Somnath Maji; Tarun Agarwal; Suman Chakraborty; Tapas K Maiti
Journal:  Clin Exp Metastasis       Date:  2018-03-13       Impact factor: 5.150

7.  Unnatural killer cells to prevent bloodborne metastasis: inspiration from biology and engineering.

Authors:  Michael J Mitchell; Michael R King
Journal:  Expert Rev Anticancer Ther       Date:  2014-05-05       Impact factor: 4.512

8.  Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  J Biomed Mater Res A       Date:  2015-03-30       Impact factor: 4.396

Review 9.  Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.

Authors:  Pedro P G Guimarães; Stephanie Gaglione; Tomasz Sewastianik; Ruben D Carrasco; Robert Langer; Michael J Mitchell
Journal:  ACS Nano       Date:  2018-02-06       Impact factor: 15.881

10.  TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.

Authors:  Elizabeth C Wayne; Siddarth Chandrasekaran; Michael J Mitchell; Maxine F Chan; Rachel E Lee; Chris B Schaffer; Michael R King
Journal:  J Control Release       Date:  2015-12-28       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.